The Business Times
business-time-50

Series C funding sends Biofourmis to near-unicorn status

Published Thu, Sep 3, 2020 · 09:50 PM

    Singapore

    HOMEGROWN startup Biofourmis has raised US$100 million in a Series C equity round led by Softbank Vision Fund 2, catapulting the healthcare company to near-unicorn status in a matter of months.

    The latest funding, which sources said has quadrupled Biofourmis' valuation from about US$200 million previously, comes despite a slowdown in healthcare investments in the Asia-Pacific over the first half of the year.

    BiofourmisSoftBankStartup fundingSeries C

    TRENDING NOW

    Chee Hong Tat, minister for national development and deputy chairman of MAS, says there will be a new Investment Management Track under ONE Pass.

    MAS allocates S$1.45 billion to five asset managers in third EQDP batch: Chee Hong Tat

    The judge finds that UOB interpreted a mainboard rule incorrectly.

    UOB found ‘grossly negligent’ over Stamford Land rights issue advice, to pay S$1.9 million

    The government on Tuesday (Sep 29) released two new private residential sites for sale.

    East Coast Road, Serangoon North View private-housing sites launched for sale

    From left: CDL’s group chief financial officer Yiong Yim Ming; group general manager Chia Ngiang Hong; group CEO Sherman Kwek; group chief operating officer Kwek Eik Sheng; and chief investment officer Gerald Yong.

    ‘My grandfather’s legacy’: Sherman Kwek lays out three-year plan for CDL to drive returns

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More